Refractory Epilepsy: Clinical Trials

2 trials for Refractory Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Refractory Epilepsy: new trials by email Literature Review of Refractory Epilepsy trials Research Report on Refractory Epilepsy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
ICV delivery of CT-010 via an implantable pump and a cranial port and dual lumen catheter (CIC), Placebo delivery via an implantable pump and a cranial port and dual lumen catheter (CIC) - Refractory Epilepsy
Phase 2TerminatedCerebral Therapeutics LLC302020-08-212024-03-13
Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
diazepam nasal spray, diazepam rectal gel - Refractory Epilepsy
Phase 2TerminatedAcorda Therapeutics782015-06-012018-10-16

Narrower conditions

Drug Resistant Epilepsy (2)  ·  Epilepsy (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Epilepsy (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Diazepam (1)

Sponsors

Acorda Therapeutics (1)  ·  Cerebral Therapeutics LLC (1)

Countries

Australia (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Lee Min Jae (1)